Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-70,281
Closed -$5.82M 1554
2022
Q3
$5.82M Buy
+70,281
New +$6.16M 0.2% 101
2022
Q2
Sell
-27,917
Closed -$3.16M 1721
2022
Q1
$3.16M Buy
+27,917
New +$3.13M 0.12% 185
2021
Q4
Sell
-70,458
Closed -$8.19M 1312
2021
Q3
$8.19M Buy
70,458
+64,017
+994% +$8.02M 0.3% 89
2021
Q2
$776K Sell
6,441
-17,234
-73% -$2.04M 0.02% 603
2021
Q1
$2.55M Sell
23,675
-17,025
-42% -$1.89M 0.08% 248
2020
Q4
$4.78M Buy
40,700
+18,500
+83% +$1.88M 0.16% 146
2020
Q3
$1.9M Buy
+22,200
New +$1.9M 0.25% 72

Other funds holding DVA

Ergoteles's DVA Position: Q4 2022 in Review

Ergoteles sold out of DaVita (DVA) in Q4 2022, closing a stake of 70,281 shares — an estimated $5.82M sold.

Ergoteles first reported a position in DVA in Q3 2020 and held it in 7 quarters. The position peaked at $8.19M in Q3 2021. 444 funds tracked by Wall St. Rank hold DVA as of Q4 2022.

  • Ergoteles reported no remaining DaVita position as of Q4 2022 after selling out during the quarter.
  • Ergoteles sold 70,281 DaVita shares in Q4 2022, an estimated $5.82M.
  • Ergoteles first reported a position in DaVita in Q3 2020 and held it in 7 quarters.
  • Ergoteles's DaVita position peaked at $8.19M in Q3 2021.
  • 444 funds tracked by Wall St. Rank held DaVita as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.